Orthofix Medical announced the 510 k clearance and first U.S. implant of the Fitbone Transport and Lengthening System. Used to treat large bone defects in the femur and tibia due to trauma, infectious or malignant conditions, the device is the only intramedullary nail designed to transport or lengthen the bone through a single surgery….The Fitbone(TM) Transport and Lengthening System, used to treat large bone defects in the femur and tibia due to trauma, infectious or malignant conditions, is the only intramedullary nail designed to transport or lengthen the bone through a single surgery. “Patients with defects to the femur and tibia can be difficult to treat and often have undergone multiple prior surgeries,” said Dr. David Frumberg, an orthopedic surgeon and Director of the Limb Restoration and Lengthening Program in New Haven, Conn., who performed the first U.S. implantation. “The Fitbone Transport and Lengthening System is a game-changing new option that enables bone to be transported across the defect, allowing very challenging problems to be treated without multiple follow-up surgeries.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OFIX:
- Orthofix named Finegan as Chair of the Board of Directors
- Orthofix Shareholders Approve Board and Key Proposals
- Orthofix appoints McPherron as President of Global Operations, Quality
- Orthofix names Julie Dewey Chief Investor Relations and Communications Officer
- Needham medtech/diagnostic analyst holds analyst/industry conference call